World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
76
Citations
18207
World Ranking
18898
National Ranking
9417

Overview

David W. Oslin is affiliated with the University of Pennsylvania in the United States. Their research primarily spans the fields of Medicine and Psychology, with significant focus in several subfields including Clinical Psychology, General Health Professions, Social Psychology, Pharmacology, and Public Health, Environmental and Occupational Health.

The main topics addressed in their work include Mental Health Treatment and Access, Suicide and Self-Harm Studies, Mental Health Research Topics, Treatment of Major Depression, Opioid Use Disorder Treatment, Health Policy Implementation Science, and Health Systems, Economic Evaluations, Quality of Life.

David W. Oslin has published extensively with research appearing frequently in venues such as Psychiatric Services, Journal of Affective Disorders, bioRxiv (Cold Spring Harbor Laboratory), The Journal of Nervous and Mental Disease, and Contemporary Clinical Trials.

Key recent papers authored or coauthored by David W. Oslin include:

  • Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder, 2022, JAMA
  • GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors, 2023, American Journal of Psychiatry
  • A genome-wide association study of suicide attempts in the million veterans program identifies evidence of pan-ancestry and ancestry-specific risk loci, 2022, Molecular Psychiatry
  • Primary care and mental health providers' perceptions of implementation of pharmacogenetics testing for depression prescribing, 2020, BMC Psychiatry
  • Identification of Novel, Replicable Genetic Risk Loci for Suicidal Thoughts and Behaviors Among US Military Veterans, 2022, JAMA Psychiatry

Collaborations are evident from frequent co-authorship with researchers such as Nathan A. Kimbrel, Benjamin H. McMahon, Jean C. Beckham, Kevin G. Lynch, and Daniel Jacobson, with counts of joint publications ranging from 11 to 15.

Best Publications

  • A Functional Polymorphism of the μ -Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients

    David W Oslin;David W Oslin;Wade Berrettini;Henry R Kranzler;Helen Pettinati

  • Family problems among recently returned military veterans referred for a mental health evaluation.

    Steven L. Sayers;Victoria A. Farrow;Jennifer Ross;David W. Oslin

  • A "SMART" Design for Building Individualized Treatment Sequences

    H. Lei;I. Nahum-Shani;K. Lynch;D. Oslin;D. Oslin

  • Improving access to geriatric mental health services: a randomized trial comparing treatment engagement with integrated versus enhanced referral care for depression, anxiety, and at-risk alcohol use.

    Stephen J. Bartels;Eugenie H. Coakley;Cynthia Zubritsky;James H. Ware

  • Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life.

    Dennis S. Charney;Charles F. Reynolds;Lydia Lewis;Barry D. Lebowitz

  • Reducing Suicidal Ideation and Depression in Older Primary Care Patients: 24-Month Outcomes of the PROSPECT Study

    George S. Alexopoulos;Charles F. Reynolds;Martha L. Bruce;Ira R. Katz

  • Long-term risk for depressive symptoms after a medical diagnosis

    Daniel Polsky;Jalpa A. Doshi;Steven Marcus;David Oslin;David Oslin

  • A Double-Blind, Placebo-Controlled Trial Combining Sertraline and Naltrexone for Treating Co-Occurring Depression and Alcohol Dependence

    Helen M. Pettinati;David W. Oslin;Kyle M. Kampman;William D. Dundon

  • Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.

    Edna B. Foa;David A. Yusko;Carmen P. McLean;Michael K. Suvak

  • Suicidal and death ideation in older primary care patients with depression, anxiety, and at-risk alcohol use.

    Stephen J. Bartels;Eugenie Coakley;Thomas E. Oxman;Giuseppe Constantino

  • Alcohol related dementia: proposed clinical criteria

    David Oslin;Roland M. Atkinson;David M. Smith;Hugh Hendrie

  • Predicting treatment response to naltrexone: the influence of craving and family history.

    John R. Monterosso;Barbara A. Flannery;Helen M. Pettinati;David W. Oslin

  • Developing adaptive treatment strategies in substance abuse research.

    Susan A. Murphy;Kevin G. Lynch;David Oslin;James R. McKay

  • The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.

    Helen M Pettinati;Charles P O'Brien;Amanda R Rabinowitz;Shoshana P Wortman

  • Assessment of late life depression.

    George S. Alexopoulos;Soo Borson;Bruce N. Cuthbert;D.P. Devanand

  • Alcoholism treatment adherence: older age predicts better adherence and drinking outcomes.

    David W. Oslin;David W. Oslin;Helen Pettinati;Joseph R. Volpicelli

  • Alcoholism in older persons: a review of the literature.

    Joseph G. Liberto;David W. Oslin;Paul E. Ruskin

  • Screening, assessment, and management of depression in VA primary care clinics. The Behavioral Health Laboratory.

    David W. Oslin;David W. Oslin;Jennifer Ross;Jennifer Ross;Steve Sayers;Steve Sayers;John Murphy;John Murphy

  • Naltrexone as an Adjunctive Treatment for Older Patients With Alcohol Dependence

    David Oslin;Joseph G. Liberto;John O'Brien;Stacy Krois

  • A genetic association study of the mu opioid receptor and severe opioid dependence.

    James J Crowley;David W. Oslin;Ashwin A. Patkar;Edward Gottheil

Frequent Co-Authors

Charles P. O'Brien
Charles P. O'Brien University of Pennsylvania
Kevin G. Lynch
Kevin G. Lynch University of Pennsylvania
Ira R. Katz
Ira R. Katz University of Pennsylvania
Henry R. Kranzler
Henry R. Kranzler University of Pennsylvania
Wade H. Berrettini
Wade H. Berrettini University of Pennsylvania
Charles A. Dackis
Charles A. Dackis University of Pennsylvania
Joel Gelernter
Joel Gelernter Yale University
James R. McKay
James R. McKay University of Pennsylvania
Raymond F. Anton
Raymond F. Anton Medical University of South Carolina
Lindsay A. Farrer
Lindsay A. Farrer Boston University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in medicine but exploring different entry points or career options? Online degrees in healthcare continue to expand, offering flexibility and affordability for many aspiring professionals. One popular pathway is medical billing and coding, which can be a quick route into the healthcare field. Curious about the investment? Learn how much does it cost to become a medical coder to see if this career aligns with your goals and budget.

Nursing remains a cornerstone of healthcare, and online nursing programs have made it easier and more affordable to get started. Compare the cheapest online nursing programs to find reputable programs that fit your financial needs.

For those who want to advance further, nurse practitioners are in high demand. Many professionals are looking for cheap online fnp programs (Family Nurse Practitioner) to attain a higher level of practice without incurring huge debts.

Finally, if your goal is to reach the highest academic level in nursing, check the options for the cheapest dnp programs (Doctor of Nursing Practice) to boost your credentials and expertise.

Best Scientists Citing David W. Oslin

Trending Scientists